This table is based on sites providing both "Number of NSCLC patients newly diagnosed" and "Number of patients tested for EGFR mutation" for a particular category. "Missing" collects number of patients not falling into the other categories in a particular factor. Blank indicates no data are available for this table, hence the proportion is not calculable. Any discrepancy between "Number of patients tested for EGFR mutation" in Table S2.2 and "Number of patients tested for mutation" in Table S1.2 is due to difference in subsets of sites used for EGFR constructing these tables. Supplementary Table S1.3. Number of cases tested for EGFR mutation by country: Histology Country Category Number of Number of % 95% CI* NSCLC cases cases tested for Lower Upper newly EGFR diagnosed mutation Total Adenocarcinoma 12455 6278 50.4 49.5 51.3 Other morphological 9850 1228 12.5 11.8 13.1 subtypes Squamous cell 6308 786 12.5 11.7 13.3 carcinoma China Adenocarcinoma 5460 1652 30.3 29.1 31.5 Other morphological 6615 530 8 7.4 8.7 subtypes Squamous cell 3604 339 9.4 8.5 10.4 carcinoma Hong Kong Adenocarcinoma 527 292 55.4 51.1 59.6 Other morphological 133 12 9 5.2 15.1 subtypes Squamous cell 109 7 6.4 3.1 12.7 carcinoma Indonesia Adenocarcinoma Other morphological subtypes Squamous cell carcinoma Japan Adenocarcinoma 1630 1128 69.2 66.9 71.4 749 412 55 51.4 58.5 Other morphological
This table is based on sites providing both "Number of NSCLC patients newly diagnosed" and "Number of patients tested for EGFR mutation" for a particular category. "Missing" collects number of patients not falling into the other categories in a particular factor. Blank indicates no data are available for this table, hence the proportion is not calculable. Any discrepancy between "Number of patients tested for EGFR mutation" in Table S2.2 and "Number of patients tested for EGFR mutation" in Table S1.2 is due to difference in subsets of sites used for constructing these tables. Supplementary Table S1.3. Number of cases tested for EGFR mutation by country: Histology Country Category Number of NSCLC cases newly diagnosed Number of cases tested for EGFR mutation % 95% CI* Lower Upper Total Adenocarcinoma 12455 6278 50.4 49.5 51.3 Other morphological subtypes 9850 1228 12.5 11.8 13.1 Squamous cell carcinoma 6308 786 12.5 11.7 13.3 China Adenocarcinoma 5460 1652 30.3 29.1 31.5 Other morphological subtypes 6615 530 8 7.4 8.7 Squamous cell carcinoma 3604 339 9.4 8.5 10.4 Hong Kong Adenocarcinoma 527 292 55.4 51.1 59.6 Other morphological subtypes 133 12 9 5.2 15.1 Squamous cell carcinoma 109 7 6.4 3.1 12.7 Indonesia Adenocarcinoma Other morphological subtypes Squamous cell carcinoma Japan Adenocarcinoma 1630 1128 69.2 66.9 71.4 Other morphological 749 412 55 51.4 58.5